Clinical Nursing Recommendations for the Treatment of the BTX-A Injections Due to Neurological Detrusor Overactivity
- 1 Departments of Emergency, The Eighth Hospital of Guangzhou, Guangdong, China
- 2 Department of Urology, Guangdong Provincial Work Injury Rehabilitation Hospital, Guangdong, China
- 3 Department of Urology, Guangdong Provincial Work Injury Rehabilitation Hospital, Guangdong, China
- 4 Department of Urology, Guangdong Provincial Work Injury Rehabilitation Hospital, Guangdong, China
- 5 Department of Urology, Guangdong Provincial Work Injury Rehabilitation Hospital, Guangdong, China
- 6 Department of Urology, Guangdong Provincial Work Injury Rehabilitation Hospital, Guangdong, China
- 7 Department of Urology, Guangdong Provincial Work Injury Rehabilitation Hospital, Guangdong, China
Abstract
Background: Neurological detrusor overactivity (NDO) is commonly associated with various neurogenic diseases. Botulinum toxin A (BTX-A) has been proposed as alternatives to traditional treatments. Objective: To summarize the clinical experience of nursing care for the treatment of the Botulinum toxin A (BTX-A) injections due to neurological detrusor overactivity (NDO). Methods: We reviewed the data of 32 inpatients who received BTX-A injections between August 2014 to July 2016. Their mean age was 27.4 years old (range: 19 - 38). They were all on clean intermittent catheterization. All patients presented detrusor overactivity resistant to oral anticholinergic treatment. Results: There were significant difference between outcomes at baseline and week12 for P detmax (60.08 cmH 2 O vs. 28.04 cmH 2 O, P < 0.001), VFIDC (165.55 ml vs. 276.07, P < 0.001), and urinary incontinence respectively. Prompt psychological counseling and nursing help reduce the patients’ passive psychology, enhance their confidence with good postoperative recovery and symptoms improvement. Conclusions: Patients were satisfied with the treatment and nursing by targeted perioperative nursing.
- Abrams, P., Cardozo, L., Fall, M., Griffiths, D., Rosier, P., Ulmsten, U., et al. (2002) The Standardisation of Terminology of Lower Urinary Tract Function: Report from the Standardisation Sub-Committee of the International Continence Society. Neurourology and Urodynamics, 21, 167-178. https://doi.org/10.1002/nau.10052
- Hagen, E.M., Eide, G.E., Rekand, T., Gilhus, N.E. and Gronning, M. (2010) Traumatic Spinal Cord Injury and Concomitant Brain Injury: A Cohort Study. Acta Neurologica Scandinavica, 122, 51-57. https://doi.org/10.1111/j.1600-0404.2010.01376.x
- Denys, P., Corcos, J., Everaert, K., Chartier-Kastler, E., Fowler, C., et al. (2006) Improving the Global Management of the Neurogenic Bladder Patient: Part I. The Complexity of Patients. Current Medical Research and Opinion, 22, 359-365. https://doi.org/10.1185/030079906X89702
- Chapple, C. and Patel, A. (2006) Botulinum Toxin: New Mechanisms, New Therapeutic Directions? European Urology, 49, 606-608. https://doi.org/10.1016/j.eururo.2006.01.005
- Schurch, B., Stöhrer, M., Kramer, G., Schmid, D.M., Gaul, G. and Hauri, D. (2000) Botulinum—A Toxin for Treating Detrusor Hyperreflexia in Spinal Cord Injured Patients: A New Alternative to Anticholinergic Drugs? Preliminary Results. Journal of Urology, 164, 692-697. https://doi.org/10.1016/S0022-5347(05)67283-7
- Stöhrer, M., Blok, B., Castro-Diaz, D., Chartier-Kastler, E., Del Popolo, G., Kramer, G., et al. (2009) EAU Guidelines on Neurogenic Lower Urinary Tract Dysfunction. European Urology, 56, 81-88. https://doi.org/10.1016/j.eururo.2009.04.028